Persistent non-A, non-B hepatitis in experimentally infected chimpanzees.

Area of Science:

• Hepatology
• Virology
• Immunology

Background:

• Non-A, non-B (NANB) hepatitis represents a significant etiological category of viral hepatitis.
• Understanding the transmission and long-term effects of NANB hepatitis is crucial for public health.
• Previous studies have indicated NANB hepatitis can be transmitted parenterally.

Purpose of the Study:

• To investigate the transmissibility of NANB hepatitis to non-human primates.
• To characterize the long-term clinical and pathological manifestations of NANB hepatitis in experimentally infected chimpanzees.
• To explore potential pathogenetic mechanisms, including the role of immune complexes.

Main Methods:

• Intravenous inoculation of NANB hepatitis infectious materials (factor VIII, liver, plasma) into six chimpanzees.
• Monitoring of serum alanine aminotransferase (ALT) levels for indicators of liver dysfunction.
• Analysis of liver biopsy specimens for histopathological changes and specific NANB hepatitis-associated structures.
• Detection of circulating immune complexes in infected animals.

Main Results:

• Successful transmission of NANB hepatitis to six chimpanzees.
• Five of six infected chimpanzees exhibited persistent or intermittent ALT elevations for over one year, indicating chronic liver dysfunction.
• Hepatocyte cytoplasmic structures associated with NANB hepatitis were detected in biopsies up to 27 months post-inoculation.
• Mild, persistent histopathological lesions were observed in liver biopsies from 13-30 months post-inoculation.
• Circulating immune complexes were detected in one chimpanzee with sustained ALT elevation.

Conclusions:

• Experimental inoculation with NANB hepatitis materials can lead to persistent liver dysfunction and pathology in chimpanzees.
• The findings suggest that NANB hepatitis can establish chronic infection in susceptible hosts.
• Immune complexes may play a role in the pathogenesis of NANB hepatitis.